(NASDAQ: TAOX) Tao Synergies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 192.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,922.46%.
Tao Synergies's earnings in 2025 is -$27,074,956.On average, 3 Wall Street analysts forecast TAOX's earnings for 2025 to be -$62,098,527, with the lowest TAOX earnings forecast at -$59,663,290, and the highest TAOX earnings forecast at -$63,924,954.
In 2026, TAOX is forecast to generate -$51,118,576 in earnings, with the lowest earnings forecast at -$49,113,926 and the highest earnings forecast at -$52,622,064.